HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearchCompany Lookup
The Week

HHS plan to speed drug R&D won't remove 'self-inflicted' delays

U.S. clinical trials continue to lose ground to China, but is Operation Trialblazer enough to help America catch up?

By PharmaVoice · Jul 8, 2026 · via PharmaVoice

This is an aggregated industry headline. Read the full story at PharmaVoice →

RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.

Tags
theweekformat:headlineheadlinePharmaVoice
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Allergan Aesthetics helps map paths for young women in STEM with Girls Inc. event
Allergan Aesthetics on Tuesday welcomed Girls Inc. participants to a panel and tour at its Allergan Medical In…
Jul 9, 2026
The WeekFierceBiotech ↗
FDA halts release of new drug rejection letters while working to formalize policy
The FDA has paused a controversial policy of releasing letters describing its rationale for rejecting drugs, F…
Jul 9, 2026
Dexcom’s OTC CGM raises pediatric, public health questions
The WeekBriefing
Dexcom’s OTC CGM raises pediatric, public health questions
The newly approved Dexcom Stelo continuous glucose monitor opens access beyond diabetes management, prompting …
Jul 9, 2026